CV Sciences (CVSI) Amortization of Deferred Charges (2015 - 2026)
CV Sciences (CVSI) reported Amortization of Deferred Charges of $65000.0 for Q1 2026, up 25.0% on a YoY basis from $52000.0 in Q1 2025, and up 3.17% sequentially from $63000.0 in Q4 2025.
CV Sciences (CVSI) Amortization of Deferred Charges (2015 - 2026) Analysis & Trends
CV Sciences (CVSI) has 8 years of Amortization of Deferred Charges data on file, last reported at $65000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 25.0% year-over-year to $65000.0; the trailing twelve-month figure through Mar 2026 stood at $251000.0 (up 71.92% YoY), and the FY2025 full-year result was $238000.0, up 95.08% from the prior year.
- Amortization of Deferred Charges grew to $65000.0 in Q1 2026, from $63000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $65000.0 in Q1 2026 to a low of $8000.0 in Q3 2024.
- A 4-year average of $45300.0 and a median of $51000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Peak annual rise in Amortization of Deferred Charges reached 687.5% in 2025, while the deepest fall reached 20.0% in 2025.
- Tracing CVSI's Amortization of Deferred Charges over 4 years: stood at $28000.0 in 2023, then grew by 28.57% to $36000.0 in 2024, then jumped by 75.0% to $63000.0 in 2025, then climbed by 3.17% to $65000.0 in 2026.
- Business Quant data shows CVSI's Amortization of Deferred Charges at $65000.0 in Q1 2026, $63000.0 in Q4 2025, and $63000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | CV Sciences | 4.11 Mn | 3.80 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,000.00 |
| Mar 31, 2026 | 65,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |